The NHS has launched an urgent campaign urging millions of UK residents to check if they qualify for a free meningococcal B (MenB) vaccine after a series of deadly outbreaks. The warning follows outbreaks earlier this year that killed three young people and infected more than 20 others, prompting the Government to roll out an emergency vaccination programme.
Who Is Eligible?
The NHS is specifically targeting young people born between September 1, 2007, and August 31, 2008, as well as under-25s starting university or residential further education for the first time this autumn. In a post on X, NHS England said: "MenB can cause meningitis and septicaemia. You may be eligible if you're: 17 to 18 years old and born between September 1 2007 and August 31 2008, or under 25 and starting university or residential further education for the first time."
How to Get Vaccinated
Those aged 17 or 18 and born between the specified dates can book online if registered with a GP in England. The vaccine is also available at participating pharmacies. Students starting university or residential further education for the first time can get the vaccine at participating pharmacies even without GP registration, but must bring proof of their university or college offer. International students and those from Scotland, Wales, Northern Ireland, the Channel Islands, and the Isle of Man are also eligible.
The vaccine is given in two doses, with the second administered at least four weeks after the first. The NHS encourages people to receive their first dose as soon as possible to ensure full protection before the autumn term begins. Those unable to book online can call 119 free of charge, where translation services are available.
Why the Urgency
Young people heading to university are at particularly high risk because the bacteria can spread through close contact, such as coughing, kissing, and sharing drinks. Infections are more likely where large numbers of students live together in halls of residence. The campaign marks the first time the MenB vaccine has been offered routinely to this age group, introduced after a spate of fatal outbreaks raised fears of further cases when students return to campuses.
